Bibliographic Details
| Title: |
Nicotine vaping was not the cause of e‐cigarette, or vaping, product use‐associated lung injury in the United States. |
| Authors: |
Mendelsohn, Colin P.1 (AUTHOR) mendel@bigpond.net.au, Wodak, Alex2 (AUTHOR), Hall, Wayne3 (AUTHOR) |
| Source: |
Drug & Alcohol Review. Feb2023, Vol. 42 Issue 2, p258-261. 4p. 1 Graph. |
| Subject Terms: |
*ELECTRONIC cigarettes, *E-cigarette or vaping product use-associated lung injuries, *NICOTINE, *PULMONARY eosinophilia |
| Geographic Terms: |
UNITED States |
| Abstract: |
MISCOMMUNICATION OF EVALI RISK BY HEALTH AUTHORITIES Some of the information from Australian governments about EVALI has been inaccurate and misleading. Nicotine vaping was not the cause of e-cigarette, or vaping, product use-associated lung injury in the United States In January 2020, the US Centers for Disease Control and Prevention (CDC) concluded that EVALI was strongly linked to vitamin E acetate [[12]]. EVALI (E-cigarette, or Vaping, product use-Associated Lung Injury) was an outbreak of severe and sometimes fatal lung injury in North America between mid-2019 and early 2020 [[1]]. [Extracted from the article] |
|
Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
